Clinical Trial Update: PGL5001 Proof of Concept Study in Inflammatory Endometriosis [Phase 2]

View source ↗

Summary

A Phase 2 proof-of-concept study of PGL5001 in inflammatory endometriosis has completed. This status indicates that final trial results are now available.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometriosis

Drugs mentioned

• PGL5001

Snippet

Sponsor: PregLem SA | Conditions: Endometriosis | Phase 2 | Status: COMPLETED